865451-74-7Relevant articles and documents
Discovery of a factor Xa inhibitor (3R,4R)-1-(2,2-difluoro-ethyl)- pyrrolidine-3,4-dicarboxylic acid 3-[(5-chloro-pyridin-2-yl)-amide] 4-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide} as a clinical candidate
Anselm, Lilli,Banner, David W.,Benz, J?rg,Groebke Zbinden, Katrin,Himber, Jacques,Hilpert, Hans,Huber, Walter,Kuhn, Bernd,Mary, Jean-Luc,Otteneder, Michael B.,Panday, Narendra,Ricklin, Fabienne,Stahl, Martin,Thomi, Stefan,Haap, Wolfgang
scheme or table, p. 5313 - 5319 (2010/10/21)
A series of (3R,4R)-pyrrolidine-3,4-dicarboxylic acid amides was investigated with respect to their factor Xa inhibitory activity, selectivity, pharmacokinetic properties, and ex vivo antithrombotic activity. The clinical candidate from this series, R1663
PROCESSES FOR THE PREPARATION OF (3R, 4R) -N- (4 -CHLOROPHENYL) -1- (2, 2-DIFLUOROETHYL) -N' - [2-FLUORO-4- (2-OXO-1 (2H) -PYRIDINYL) PHENYL] -3, 4-PYRROLIDINEDICARBOXAMIDE
-
Page/Page column 31, (2008/12/06)
The invention is concerned with processes for the manufacture of pyrrolidine-3,4- dicarboxamide derivative of formula (I), and the intermediates useful for those processes.
NEW SOLID FORMS OF FXA INHIBITORS
-
, (2009/01/20)
The invention is concerned with crystalline forms or amorphous forms of a pyrrolidine- 3,4-dicarboxamide derivative, which is useful as an active ingredient of medicaments for the diseases which can be treated by the coagulation factor Xa inhibitors.
NOVEL PYRROLIDINE-3,4-DICARBOXAMIDE DERIVATIVES
-
Page/Page column 40, (2008/06/13)
The invention is concerned with novel pyrrolidine-3,4-dicarboxamide derivatives of Formula (I) ; wherein Rl to R9 and X are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These c